MarketScreener Homepage > Equities > TSX VENTURE EXCHANGE > ImmunoPrecise Antibodies Ltd. IPA CA45257F2008

Report

Delayed TSX VENTURE EXCHANGE - 01/27 03:59:59 pm
20.1	CAD		+2.34%

01/18

IMMUNOPRECISE ANTIBODIES : to Begin Trading on Nasdaq Stock Exchange

01/18

IMMUNOPRECISE ANTIBODIES : Partners on Launch of SARS-CoV-2 Nanomedicine Therapy Program

01/18

IMMUNOPRECISE ANTIBODIES : to Participate in January Conferences

Most relevant news about IMMUNOPRECISE ANTIBODIES LTD.

01/18	IMMUNOPRECISE ANTIBODIES : to Begin Trading on Nasdaq Stock Exchange	PU
01/18	IMMUNOPRECISE ANTIBODIES : Partners on Launch of SARS-CoV-2 Nanomedicine Therapy..	PU
01/18	IMMUNOPRECISE ANTIBODIES : to Participate in January Conferences	PU
01/18	IMMUNOPRECISE ANTIBODIES : Announces Grant of Stock Options	PU
01/06	IMMUNOPRECISE ANTIBODIES : Announces Grant of Stock Options	BU
01/06	IMMUNOPRECISE ANTIBODIES : to Participate in January Conferences	BU
2020	Update - Dual Listed ImmunoPrecise Down 10% on TSX As Partners on Launch of S..	MT
2020	IMMUNOPRECISE ANTIBODIES : Dual Listed ImmunoPrecise Partners on Launch of SARS-..	MT
2020	IMMUNOPRECISE BRIEF : Partners on Launch of SARS-CoV-2 Nanomedicine Therapy Prog..	MT
2020	IMMUNOPRECISE ANTIBODIES : Partners on Launch of SARS-CoV-2 Nanomedicine Therapy..	BU
2020	ImmunoPrecise Antibodies to Begin Trading on the NASDAQ	MT
2020	IMMUNOPRECISE ANTIBODIES : to Begin Trading on Nasdaq Stock Exchange	AQ
2020	IMMUNOPRECISE ANTIBODIES : Reports 50% Jump in Revenue to $4.75 Million For Q2 2..	MT
2020	IMMUNOPRECISE ANTIBODIES : Reports Financial Results and Recent Business Highlig..	AQ
2020	IMMUNOPRECISE ANTIBODIES : Collaboration Enables Preclinical Manufacturing of Le..	AQ

All news about IMMUNOPRECISE ANTIBODIES LTD.

01/18	IMMUNOPRECISE ANTIBODIES : to Begin Trading on Nasdaq Stock Exchange	PU
01/18	IMMUNOPRECISE ANTIBODIES : Partners on Launch of SARS-CoV-2 Nanomedicine Therapy..	PU
01/18	IMMUNOPRECISE ANTIBODIES : to Participate in January Conferences	PU
01/18	IMMUNOPRECISE ANTIBODIES : Announces Grant of Stock Options	PU
01/06	IMMUNOPRECISE ANTIBODIES : Announces Grant of Stock Options	BU
01/06	IMMUNOPRECISE ANTIBODIES : to Participate in January Conferences	BU
2020	Update - Dual Listed ImmunoPrecise Down 10% on TSX As Partners on Launch of S..	MT
2020	IMMUNOPRECISE ANTIBODIES : Dual Listed ImmunoPrecise Partners on Launch of SARS-..	MT
2020	IMMUNOPRECISE BRIEF : Partners on Launch of SARS-CoV-2 Nanomedicine Therapy Prog..	MT
2020	IMMUNOPRECISE ANTIBODIES : Partners on Launch of SARS-CoV-2 Nanomedicine Therapy..	BU

News in other languages on IMMUNOPRECISE ANTIBODIES LTD.

01/07	IMMUNOPRECISE ANTIBODIES : annonce l'attribution d'options de souscription d'act..
01/06	IMMUNOPRECISE ANTIBODIES : annonce sa participation à des conférences en janvier
2020	IMMUNOPRECISE ANTIBODIES : s'associe au lancement du programme de thérapie nanom..

Press releases

01/18	IMMUNOPRECISE ANTIBODIES : to Begin Trading on Nasdaq Stock Exchange	PU
01/18	IMMUNOPRECISE ANTIBODIES : Announces Grant of Stock Options	PU
01/18	IMMUNOPRECISE ANTIBODIES : Partners on Launch of SARS-CoV-2 Nanomedicine Therapy..	PU
01/18	IMMUNOPRECISE ANTIBODIES : to Participate in January Conferences	PU
01/06	IMMUNOPRECISE ANTIBODIES : Announces Grant of Stock Options	BU

Upcoming event on IMMUNOPRECISE ANTIBODIES LTD.

03/31/21

Upcoming sector events

01/28/21	LUPIN LIMITED : Q3 2021 Earnings Release
01/28/21	SUMITOMO DAINIPPON PHARMA CO., LTD. : Q3 2020 Earnings Release
01/29/21	ASTELLAS PHARMA INC. : Q3 2020 Earnings Release
01/28/21	DAIICHI SANKYO COMPANY, LIMITED : Q3 2020 Earnings Release

Sector

Healthcare
	Pharmaceuticals & Medical Research
		Pharmaceuticals
			Pharmaceuticals
				Biopharmaceuticals